Ken Barlow is a seasoned quality engineer currently employed at Boeing since December 2025, previously holding the same position at AGC Electronics America from January to November 2025. Barlow has extensive experience in life sciences and biopharmaceuticals, serving as an advisory life science engineer at Funai Solutions from September 2022 to November 2024, and leading a team at Absci from November 2017 to August 2022 as Scientist I, Team Leader, focusing on strain screening workflows and scalable purification processes. Prior roles include senior research associate at CytomX Therapeutics, where early phase downstream processes for modified antibodies were developed, and research associate II at BioMarin Pharmaceutical Inc., specializing in enzyme purification for replacement therapies. Barlow's career began at Merck, contributing to protein purification processes for clinical trials, and included an internship at Merck and a manufacturing associate role at Baxter International Inc. Barlow holds a BS in Biochemistry from the University of Oregon and a Master of Engineering in Biological Chemical Engineering from Lehigh University.
This person is not in any teams
This person is not in any offices